Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Alimentary Pharmacology & Therapeutics|January 20, 2018
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) surveyP Olivera, W J Sandborn, J Panés, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2011
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximabB G Feagan, W J Sandborn, D C Wolf, et al.
Mayo Clinic Proceedings|February 1, 1997
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel diseaseA M Levy, G J Gleich, W J Sandborn, et al.
Gastroenterology|December 1, 1995
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's diseaseW J Sandborn, E C Van O, B J Zins, et al.
Italian Journal of Gastroenterology and Hepatology|October 6, 1998
Nicotine carbomer enemas--pharmacokinetics of a revised formulationJ T Green, J Rhodes, G A Thomas, et al.
The American Journal of Gastroenterology|January 11, 2001
Intravenous azathioprine in severe ulcerative colitis: a pilot studyU Mahadevan, W J Tremaine, T Johnson, et al.
Mayo Clinic Proceedings|July 1, 1997
Dexpanthenol enemas in ulcerative colitis: a pilot studyE V Loftus, W J Tremaine, R A Nelson, et al.
Digestive Diseases and Sciences|March 18, 1999
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot studyP Angulo, A E Bharucha, R A Jorgensen, et al.
Gastroenterology|February 1, 1996
Risk of colorectal neoplasia in patients with primary sclerosing cholangitisE V Loftus, W J Sandborn, W J Tremaine, et al.
The American Journal of Gastroenterology|October 29, 2000
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopyP J Limburg, D A Ahlquist, W J Sandborn, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|January 20, 2018
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) surveyP Olivera, W J Sandborn, J Panés, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2011
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximabB G Feagan, W J Sandborn, D C Wolf, et al.
Mayo Clinic Proceedings|February 1, 1997
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel diseaseA M Levy, G J Gleich, W J Sandborn, et al.
Gastroenterology|December 1, 1995
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's diseaseW J Sandborn, E C Van O, B J Zins, et al.
Italian Journal of Gastroenterology and Hepatology|October 6, 1998
Nicotine carbomer enemas--pharmacokinetics of a revised formulationJ T Green, J Rhodes, G A Thomas, et al.
The American Journal of Gastroenterology|January 11, 2001
Intravenous azathioprine in severe ulcerative colitis: a pilot studyU Mahadevan, W J Tremaine, T Johnson, et al.
Mayo Clinic Proceedings|July 1, 1997
Dexpanthenol enemas in ulcerative colitis: a pilot studyE V Loftus, W J Tremaine, R A Nelson, et al.
Digestive Diseases and Sciences|March 18, 1999
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot studyP Angulo, A E Bharucha, R A Jorgensen, et al.
Gastroenterology|February 1, 1996
Risk of colorectal neoplasia in patients with primary sclerosing cholangitisE V Loftus, W J Sandborn, W J Tremaine, et al.
The American Journal of Gastroenterology|October 29, 2000
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopyP J Limburg, D A Ahlquist, W J Sandborn, et al.
Pageof 19